The partnership will bring together the well-known global range of nutritional health solutions as well as vitamin, minerals, herbals and supplements of Nestle Health Science (NHSc) and also leverage the commercial capabilities of Dr. Reddy’s.
Select brands will be licensed by the JV partners to the JV company.
The Nestle Group will license brands such as Nature’s Bounty, Osteo Bi-Flex, Ester-C, Resource High Protein, Optifast, Resource Diabetic, Peptamen, Resource Renal and Resource Dialysis. Dr. Reddy’s will license brands such as Rebalanz, Celevida, Antoxid, Kidrich-D3, Becozinc in the nutrition, and OTC segments. The JV company will be headquartered in Hyderabad is expected to become operational in Q2 of FY25.
“This joint venture will enable us to build a robust retail and distribution network to take our brands closer to consumers and making a meaningful difference to improve the quality of life,” said Suresh Narayanan, chairman and managing director, Nestlé India.
“This novel approach of leveraging mutually complementary strengths of both parent companies will enable better access and affordability for consumers,” said M.V. Ramana, CEO – Branded Markets (India & Emerging Markets), Dr. Reddy’s.
